<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for BMRN</title>
    <link />
    <description>Headlines for BioMarin Pharmaceutical</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>BioMarin Pharmaceutical Inc. Presents at UBS Global Healthcare Conference, May-21-2013 09:00 AM</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1450011-biomarin-pharmaceutical-inc-presents-at-ubs-global-healthcare-conference-may-21-2013-09-00-am.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 11:40:12 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11927295/1/cramers-mad-money-recap-think-dividends-not-coupons.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 20:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447111-catalyst-pharmaceutical-s-cpp-115-may-be-big-pipeline-in-just-one-little-pill.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 11:30:31 GMT</pubDate>
    </item>
    <item>
      <title>Biomarin Stock Falls On Unusually High Volume (BMRN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926246/1/biomarin-stock-falls-on-unusually-high-volume-bmrn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 16 May 2013 16:04:00 GMT</pubDate>
    </item>
    <item>
      <title>1 Biotech, 1 Financial And 1 Grocery Store With Recent Intensive Insider Selling</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1440031-1-biotech-1-financial-and-1-grocery-store-with-recent-intensive-insider-selling.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 10:13:15 GMT</pubDate>
    </item>
    <item>
      <title>10 ASCO '13 Abstracts You Can Read Right Now</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923326/1/10-asco-13-abstracts-you-can-read-right-now.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Biomarin Reaches New 52-Week High (BMRN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11921397/1/biomarin-reaches-new-52-week-high-bmrn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 13 May 2013 10:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected To Outperform</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1389091-why-biomarin-catalyst-pharmaceutical-partners-and-vertex-are-expected-to-outperform.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 11:17:08 GMT</pubDate>
    </item>
    <item>
      <title>BioMarin Widens Loss, Maintains View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98144/biomarin-widens-loss-maintains-view.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 29 Apr 2013 11:30:01 GMT</pubDate>
    </item>
    <item>
      <title>BioMarin Pharmaceutical Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1374461-biomarin-pharmaceutical-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 25 Apr 2013 22:20:08 GMT</pubDate>
    </item>
    <item>
      <title>Catalyst Deserves The Attention</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1360441-catalyst-deserves-the-attention.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 04:43:06 GMT</pubDate>
    </item>
    <item>
      <title>Biomarin Reaches New 52-Week High (BMRN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11900647/1/biomarin-reaches-new-52-week-high-bmrn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 19 Apr 2013 15:53:00 GMT</pubDate>
    </item>
    <item>
      <title>These 4 'High-Potential' Biotech Stocks Could Outperform In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1352701-these-4-high-potential-biotech-stocks-could-outperform-in-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 16:22:10 GMT</pubDate>
    </item>
    <item>
      <title>BioMarin Attains 52-Week High - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96892/biomarin-attains-52-week-high.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 11 Apr 2013 18:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Short Interest Moves 62% Lower For BMRN</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11892424/1/short-interest-moves-62-lower-for-bmrn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 10 Apr 2013 14:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Biomarin Stock Hits New 52-Week High (BMRN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11892351/1/biomarin-stock-hits-new-52-week-high-bmrn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 10 Apr 2013 13:49:00 GMT</pubDate>
    </item>
    <item>
      <title>The 9 Levels Of Healthcare / Biotechnology And Who Should Invest - Part 1</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1324331-the-9-levels-of-healthcare-biotechnology-and-who-should-invest-part-1.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 05 Apr 2013 17:29:08 GMT</pubDate>
    </item>
    <item>
      <title>BioMarin Files CTA for BMN-190 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96165/biomarin-files-cta-for-bmn-190.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 03 Apr 2013 09:50:01 GMT</pubDate>
    </item>
    <item>
      <title>BMRN Seeks US Approval of Vimizim - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96103/bmrn-seeks-us-approval-of-vimizim.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 02 Apr 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: HES ALXN BMRN NFLX ENB AWK</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11884281/1/cramers-top-stock-picks-hes-alxn-bmrn-nflx-enb-awk.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 02 Apr 2013 06:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
